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STAT3 transcription factor signaling in specific T
helper cell differentiation has been well described,
although the broader roles for STAT3 in lymphocyte
memory are less clear. Patients with autosomal-domi-
nant hyper-IgE syndrome (AD-HIES) carry dominant-
negative STAT3 mutations and are susceptible to
a variety of bacterial and fungal infections. We found
that AD-HIES patients have a cell-intrinsic defect in
the number of central memory CD4+ and CD8+ T cells
compared to healthy controls. Naive T cells from AD-
HIESpatientshad lowerexpressionofmemory-related
transcription factors BCL6 and SOCS3, a primary
proliferation defect, and they failed to acquire central
memory-like surface phenotypes in vitro. AD-HIES
patientsshowedadecreasedability tocontrolvaricella
zoster virus (VZV) andEpstein-Barr virus (EBV) latency,
and T cell memory to both of these viruses was com-
promised. These data point to a specific role for
STAT3 in human central memory T cell formation and
in control of certain chronic viruses.
INTRODUCTION
T cell memory is critical to the maintenance of immunity against
many common pathogens. An understanding of how T cell
memory is generated and maintained is necessary to design
rational therapies and vaccines to protect against infections.
T cell receptor signal strength, costimulation, and the presence
of cytokines all contribute to differentiation of naive T cells into
effector cells and memory cells (Cui and Kaech, 2010). In hu-
mans, it is thought that central memory T cells can home to the
lymphoid organs and provide long-term T cell immunity through
self-renewal, whereas effector memory T cells migrate to the806 Immunity 35, 806–818, November 23, 2011 ª2011 Elsevier Inc.periphery where they rapidly respond to secondary antigen
exposure (Sallusto et al., 2010). The precise ontogeny of these
populations along with the specific types of infections and path-
ogens against which they protect is not entirely understood.
Signal transducer and activator of transcription-3 (STAT3) is
a latent cytoplasmic transcription factor with a wide variety of
functions in mammalian cells (Levy and Lee, 2002). Within the
immune system, STAT3 functions are noted in T cells, B cells,
neutrophils, and macrophages among others. Particular atten-
tion has been paid to the effects of STAT3 on T and B cell matu-
ration, differentiation, and function. The differentiation of several
CD4+ helper T (Th) cell subsets including Th17 cells, follicular
helper T cells, and possibly Th2 cells appears to be dependent
upon STAT3 (Eddahri et al., 2009; Nurieva et al., 2008; Vogelzang
et al., 2008; Yang et al., 2007). Mice lacking STAT3 within the
CD4+ T cell compartment demonstrate impaired antifungal and
antibacterial responses, poor germinal center formation, and
defects in antibody production (Conti et al., 2009; Eddahri
et al., 2009; Nurieva et al., 2008).
Several STAT3-dependent cytokines and transcription factors
have critical roles in shaping CD8+ T cell memory responses
in mouse models. IL-21 signaling, which depends on STAT3,
promotes memory formation, sustained functionality, and, ulti-
mately, viral clearance during chronic lymphocytic choriomenin-
gitis virus (LCMV) infection (Elsaesser et al., 2009; Fro¨hlich et al.,
2009; Yi et al., 2009). IL-10-deficient mice infected with Listeria
monocytogenes generate reduced numbers of memory T cells
that fail to protect upon secondary challenge (Foulds et al.,
2006). Other mouse models have revealed a critical role for
STAT3-regulated transcription factors Blimp-1 (encoded by
PRDM1) and Bcl6 (BCL6), both of which tend to counterregulate
the other, in the generation of effector and central memory CD8
T cells, respectively (Ichii et al., 2002, 2004; Kallies et al., 2009;
Rutishauser et al., 2009; Shin et al., 2009). Recent work has
demonstrated an important role for SOCS3 in the control of
chronic LCMV infections downstream of IL-6 signaling (Pellegrini
et al., 2011). Thedirectmechanistic role theSTAT3pathwayplays
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role in CD4+ T cell memory in particular is not well understood.
Autosomal-dominant hyper-IgE syndrome (AD-HIES) is
caused by dominant-negative STAT3 mutations and is charac-
terized by recurrent mucocutaneous candidiasis, staphylo-
coccal skin and lung infections, dermatitis, elevated IgE, and
a variety of skeletal and connective tissue abnormalities (Holland
et al., 2007; Minegishi et al., 2007). Lymphocyte abnormalities
previously observed in AD-HIES patients include defective
Th17 cell differentiation (de Beaucoudrey et al., 2008; Ma et al.,
2008; Milner et al., 2008; Renner et al., 2008), decreased
CD45RA T cells in children compared to normal adults (Buckley
et al., 1991; Young et al., 2007), decreased memory B cells
(Speckmann et al., 2008), and an increased risk for Epstein-
Barr virus (EBV)-positive and EBV-negative lymphoma formation
(Kuma´novics et al., 2010).
We used the opportunity presented by STAT3 mutant AD-
HIES patients to examine the role of STAT3 in the generation
and maintenance of lymphocyte memory. We found that these
patients had increased numbers of naive T cells and fewer
central memory CD4+ and CD8+ T cells despite enhanced cell
turnover in the absence of increased cell death. This observa-
tion appeared to be due to a defect in proliferation and differen-
tiation from naive precursors and diminished expression within
the naive compartment of transcription factors important for
memory differentiation. As a potential consequence of the
memory defects, HIES patients were found to have a previously
unrecognized predisposition to develop varicella zoster virus
(VZV) reactivation and EBV viremia.
RESULTS
Patients with AD-HIES Have Fewer Central Memory
T Cells
We recruited a cohort of 19 AD-HIES patients and 10 age-
matched healthy controls (ages 30–56) with mutations in the
SH2, DNA binding, and transactivation domain of STAT3. We
observed a decrease in the frequency of CD4+ and CD8+ central
memory (CD3+CD27+CD45RO+) T cells in AD-HIES patients
compared to controls (Figure 1A). The total numbers of CD4+
and CD8+ central memory (CD3+CD27+CD45RO+) T cells were
significantly decreased in the AD-HIES patients (mean reduction
of 45% in the CD4+ subset and 60% in the CD8+ subset) (Fig-
ure 1B). A corresponding increase was observed in the number
of naive (CD27+CD45RO) T cells in AD-HIES patients (Fig-
ure 1C). When compared to wild-type naive T cells, the CD27+
CD45RO T cells from AD-HIES patients had similar expression
of CD31, a marker of recent thymic emigrants (Figure S1A
available online). Sorted CD31+CD27+CD45RO CD4 and CD8
T cells from AD-HIES and control patients had similar numbers
of T cell receptor excision circles (TRECs) and were consistent
with previous reports in normal subjects (Figure S1B; Kimmig
et al., 2002). Additionally, CD28 expression and decreased ex-
pression of CD11a were similar in AD-HIES and control CD27+
CD45ROCD4+ T cells (Figure S1C). Thus, AD-HIES CD27+
CD45ROCD4+ T cells appear to be phenotypically and func-
tionally naive.
Effector memory (CD3+CD27CD45RO+/) T cell numbers
were similar in both AD-HIES patients and controls (Figure S1D).ICD127, an important central memory surface marker (Kaech
et al., 2003), was lower in AD-HIES central memory T cells
(Figures 1D, 1E, and S1E). Similar to recent clinical findings,
we have not noted any correlation between the genotype of
the AD-HIES patients and observed the central memory pheno-
type (Heimall et al., 2011). Patients with HIES therefore have
a focal diminution in T cells with a central memory phenotype
coupled with an apparent accumulation of naive T cells.
AD-HIES T Cells Have an Intrinsic Defect in Memory
Differentiation
We next examined whether the observed defect in central
memory T cell differentiation was intrinsic to the CD4+ and/or
CD8+ T cells as opposed to a failure of help from other cellular
sources or soluble mediators. A patient was identified with
normal frequencies of central memory CD4+ and CD8+ T cells,
yet they had two children with germline STAT3 mutations and
abnormal central memory T cell counts (Figure 2A). The patient
was found to be mosaic for an AD-HIES STAT3 mutation (Fig-
ure 2B and data not shown). Quantitative PCR measurement of
the mutant STAT3 allele (G1145ASTAT3) from the AD-HIES
mosaic patient found detectable mutant allele in the patient’s
naive CD4+ and CD8+ T cells but not in their central or effector
memory T cells (Figures 2B and 2C). As a control, the frequency
of an unlinked single-nucleotide polymorphism (SNP) was deter-
mined to be 50% of alleles in naive as well as memory T cell pop-
ulations (Figure 2B). Of note, memory B cells from the mosaic
patient had the same frequency of mutant STAT3 allele as naive
B cells, arguing against a B cell-intrinsic defect, and suggesting
that a different mechanism underlies the B cell memory deficit
observed in AD-HIES (Figures 2D and S2B; Avery et al., 2010).
The T cell-intrinsic memory defect appears to be due in part to
enhanced reliance upon IL-2 because in vitro expansion of
sorted naive CD4+ T cells from the STAT3 mosaic patient in
the presence of IL-2Ra (Daclizumab) antibody resulted in a
marked reduction of mutant STAT3 allele frequency after
10 days in culture (Figure 2E). Thus the T cell memory defect in
AD-HIES appears to be cell intrinsic, potentially resulting from
increased reliance upon IL-2, whereas the B cell memory defi-
ciency is not cell intrinsic.
Decrease in Central Memory T Cells in AD-HIES Is Not
due to Differences in Apoptosis or Turnover
We investigated further the mechanisms for the reduction in
central memory T cells in AD-HIES. The frequency of naive and
memory apoptotic T cells from 48 hr in vitro incubation was
not significantly different between AD-HIES and control cells,
suggesting that death was not increased (Figure 3A). Cell turn-
over in vivo as measured by Ki67 expression in the T cell subsets
was not diminished, either (Figures 3B and 3C). Interestingly,
turnover increased in the central memory and CD4+ T cell
effector memory compartment of AD-HIES patients (Figures
3B and 3C). This increased cell turnover may be a homeostatic
response to the relative reduction in central memory T cells, an
interpretation supported in part by a detectable increase in
serum IL-15 concentrations in AD-HIES patients (Figure 3D).
No significant difference in IL-2 or IL-7 concentrations was
observed in AD-HIES patients (Figure 3D). Therefore, the central
memory defect in AD-HIES patients would not appear to be duemmunity 35, 806–818, November 23, 2011 ª2011 Elsevier Inc. 807
Figure 1. Patients with AD-HIES Have Fewer Central Memory T Cells
(A) The frequencies of naive (CD27+CD45RO), central (CD27+CD45RO+), and effector (CD27CD45RO+/) memory T cells were measured in AD-HIES patients
and healthy age-matched controls by flow cytometry. Representative graphs and gating from age-matched subjects. Cells are gated singlet, aqua viabilityCD3+.
(B) Absolute lymphocyte counts were used to calculate the number of central memory lymphocytes in each population. *p = 0.0083, **p = 0.0036.
(C) A concomitant increase in the number of naive (CD27+CD45RO) T cells was observed in AD-HIES patients. Data are compiled from seven independent
experiments. ***p = 0.0261, *p = 0.0160.
(D and E) CD127 expression on central memory (CD27+CD45RO+) T cells was measured by flow cytometry.
(D) Representative histograms of CD127 expression on CD27+CD45RO+ central memory T cells.
(E) Mean fluorescence intensity of CD127 on the surface of central memory AD-HIES T cells was lower than that of control cells. **p = 0.0317, ***p = 0.0635.
Data are representative of two similar experiments. All horizontal bars represent median values, and significance was calculated with a two-tailed Mann-Whitney
t test with a 95% confidence interval.
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over sufficiently in vivo, but an increased reliance upon IL-2 for
competitive fitness as well as a variable initial effector response
may contribute to the phenotype.
Impaired In Vitro Induction of Central Memory T Cell
Phenotypes
Given the observed increase in naive T cells in AD-HIES patients
and the decrease in CD127 expression within the central
memory cells, we speculated that there might be a primary
defect in the proliferation and differentiation of naive T cells
into cells with central memory phenotypes. Cultures of sorted
naive CD4+ and CD8+ T cells from most AD-HIES patients stim-
ulated with anti-CD3 and anti-CD28 in the presence of IL-2
demonstrated impaired proliferation compared to healthy con-
trols as measured by CFSE dilution and proportion of live blast-
ing cells at the end of the culture (Figures 4A and S3A–S3C)
Sorted naive T cells from two different samples obtained from
a single AD-HIES patient cultured under the same conditions
had similar blasting phenotypes when compared to their respec-
tive control, implying that the ability to blast may not be highly
variable within each patient (data not shown). This defect would
not appear to be due to impaired activation and upregulation of
CD25 (Figure S3D) despite evidence in mice that T cells deficient
in STAT3 fail to efficiently upregulate CD25 upon activation
(Akaishi et al., 1998). Additionally, we observed no link between
the domain of STAT3 mutated in the patient and their ability to
blast in vitro.
IL-7 and IL-15 have been demonstrated to play key roles in
memory T cell homeostasis and differentiation (Kaech et al.,
2003; Ku et al., 2000; Peschon et al., 1994). Short-term
in vitro stimulation and expansion of naive T cells in the pres-
ence of IL-2, IL-7, or IL-15 can lead to the differentiation into
effector or central memory-like surface phenotypes in several
mouse models, which correlate to their appropriate memory
functions upon adoptive transfer (Carrio et al., 2004; Manjunath
et al., 2001). Naive T cells from AD-HIES patients were similarly
stimulated for 4 to 6 days in the presence of IL-2, IL-7 (CD4+),
or IL-15 (CD8+). In at least four individual experiments with four
different patients and controls, we found that those AD-HIES
T cells that did divide had a reduction, in some cases marked,
in the frequency of CD45RO+CD62Lhi cells (Figures 4C, 4D,
and S4A) in the presence of IL-7 (CD4) or IL-15 (CD8). In most
cultures, upregulation of CD45RO was decreased in AD-
HIES patients as a function of division number compared to
controls (Figure S4B). Of note, IL-2 treatment alone did not
appear to drive an effector memory phenotype as seen in the
mouse models, perhaps reflecting differences between the
species (Figures S4C and S4D). Regardless, with this human
in vitro model, division of activated naive T cells was mark-
edly impaired, as was the capacity for dividing T cells with
STAT3 mutations to differentiate into a central memory-like
phenotype.
Naive STAT3 Mutant T Cells Have Impaired Expression
of Transcription Factors Related to Central Memory
T Cell Differentiation
The impaired in vitro central memory differentiation was associ-
ated with decreased expression of two STAT3-responsive tran-Iscription factors important in the development of T cell memory,
BCL6 and SOCS3 (Ichii et al., 2002, 2004; Pellegrini et al., 2011),
within the naive T cell compartment of many AD-HIES patients
(Figure 5A). The decreased presence of BCL6 and SOCS3 tran-
scripts in AD-HIES naive T cells, coupled with the proliferation
defect, may contribute to their decreased ability to become
CD45RO+CD62Lhi in vitro as well as the increased naive T cell
pool and the lower numbers of centralmemory cells found in vivo.
Central memory CD8 T cells had a more effector memory-like
transcriptional profile in AD-HIES patients. In control subjects,
BCL6 was elevated in the central memory CD8 T cells and
PRDM1was elevated in effectormemory populations in a pattern
similar to that seen in mouse models of memory T cell differenti-
ation (Figures 5B and S5; Rutishauser et al., 2009). However,
sorted ex vivo AD-HIES central memory T cells expressed less
BCL6 than controls, and effector memory cells expressed
more PRDM1 than controls (Figures 5B, 5C, and S5). The altered
expression of these key transcription factors as well as the lower
surface expression of CD127 also suggests that the fewer AD-
HIES T cells that succeed in differentiating in vivo into central
memory T cells do not possess a typical central memory T cell
phenotype, which could therefore lead to defects in function
independent of number. The failure to acquire central memory
phenotypes may therefore be linked to impaired expression of
STAT3-dependent transcription factors that are important for
memory differentiation.
AD-HIES Patients Have an Increased Risk for VZV
Reactivation and EBV Viremia
AD-HIES patients are highly susceptible to bacterial and fungal
infections but appear to control primary viral infections normally
(Freeman and Holland, 2010). In an attempt to find clinical corre-
lates to the observed central memory T cell defects, we surveyed
AD-HIES patients for evidence of impaired control of chronic
viral infections. We found that nearly one third of AD-HIES
patients had a history of reactivation of VZV (herpes zoster, shin-
gles) at relatively young ages (Figure 6A and Table 1). Starting
the second decade of life and onward, the incidence rates of re-
activation were 20.6, 11.1, 17.6, and 70.2 cases, respectively,
per 1000 person years (Table 1). These rates were 6- to 20-fold
higher than the rate of herpes zoster in the general population
(1 to 3 per 1000 person years) over the same decades of life (Do-
nahue et al., 1995; Hope-Simpson, 1975; Yawn et al., 2007). The
recurrence rate of herpes zoster in AD-HIES patients was 27.4
per 1000 person years after initial reactivation (5 of 19 patients,
26.3%), which is a substantial increase over the general popula-
tion’s estimated rate of 7.4 per 1000 person years (Donahue
et al., 1995).
Although VZV-specific antibody titers in AD-HIES appear
normal (Avery et al., 2010), we measured CD4+ T cell responses
to VZV given that these cellular responses appear to be the most
tightly correlated to risk for reactivation (Burke et al., 1982). We
found that the increased incidence of herpes zoster in AD-
HIES patients was associated with a reduction in the number
of memory CD4+ T cells, which produced either IL-2, IFN-g, or
TNF-a in response to VZV-infected cell lysate compared to
controls, regardless of patient history of VZV reactivation
(Figures 6B and S6). The responding cell population was too
small to differentiate central from effector memory phenotypes.mmunity 35, 806–818, November 23, 2011 ª2011 Elsevier Inc. 809
Figure 2. AD-HIES T Cells Have an Intrinsic Defect in Memory Differentiation
(A) The frequency of central memory CD4+ T cells in a patient mosaic for an AD-HIES STAT3 mutation (G114ASTAT3) and their AD-HIES child. Cells are gated
CD3+CD4+CD27+. Naive (rectangle, CD27+CD31+CD45RO) and central memory (circle, CD27+CD31CD45RO+) mosaic AD-HIES T cells were purified by flow
cytometry and the frequency of G1145ASTAT3 alleles determined by real-time PCR.
(B) Chromatographs of STAT3 and a control SNP (intron 13, rs2293152) depict the relative presence of mutant and normal STAT3 alleles in the naive andmemory
CD4+ population.
(C) Naive (CD31+CD27+CD45RO), central (CD31CD27+CD45RO+), and effector memory (CD31CD27+CD45RO+/) CD4+ and CD8+ T cells were sorted from
the mosaic AD-HIES patient and subjected to sequence-specific real-time PCR for the G114ASTAT3 allele. Real-time PCR measurements of mutant STAT3
alleles were measured in two independent experiments.
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a portion of which are EBV positive. We therefore measured
EBV viremia and found that 54% of EBV antibody titer-positive
AD-HIES patients had EBV+ peripheral blood mononuclear cells
(PBMCs) whereas only 14%of controls had detectable EBVDNA
in the blood. AD-HIES EBV+ PBMCs had markedly higher viral
loads than EBV+ controls (Figure 6C). Although the overall
numbers of EBV-reactive memory CD4+ and CD8+ T cells were
similar between AD-HIES patients and controls (Figure 6D), the
EBV viremia observed in AD-HIES individuals was associated
with lower frequencies of EBV-reactive central memory CD4+
and CD8+ T cells (Figures 6E and 6F). Cytomegalovirus (CMV)
viremia, which can be better controlled when donor marrow is
enriched for CMV-specific central memory T cells in transplant
settings (Scheinberg et al., 2009), was not detected in the
PMBCs of any AD-HIES patients or controls.
DISCUSSION
AD-HIES patients have decreased numbers of central memory
T cells in part because of an intrinsic defect in their ability to
proliferate and differentiate from naive precursors. Central
memory CD8+ T cells from AD-HIES patients had a more
effector-like transcriptional profile, and both CD4+ and CD8+
central memory T cells had lower expression of CD127. The
partial effacement of the central memory compartment in AD-
HIES patients is associated with a failure to control VZV and
EBV but appears to largely confer sufficient protection against
other viruses, including CMV, which is seen only in more severe
settings of T cell compromise such as bone marrow transplant,
severe combined immunodeficiency, and advanced HIV (Kost
and Straus, 1996; Steininger, 2007). Other congenital immune
deficiencies characterized by mature B cell (Faulkner et al.,
1999; Winkelstein et al., 2006), or Th17 cell defects (Ferwerda
et al., 2009; Glocker et al., 2009; Puel et al., 2011) are not asso-
ciated with abnormal VZV or EBV responses, arguing against
a role for those defects that are normally observed in AD-HIES
as a cause for the diminished capacity to control chronic viruses.
Additionally, the relatively intact naive and effectormemory pools
may explain the failure to observe pathology from primary and
recurrent viral infections in AD-HIES patients. This finding in
AD-HIES appears unique in that no other known human immune
deficiencies present from birth are characterized by increased
rates of VZV reactivation in the absence of significant pathology
when encountering primary VZV.
Our studies have revealed a role for STAT3 in CD4+ and CD8+
T cell memory separate from its role in T helper cell functional
differentiation. STAT3 mutations in AD-HIES patients demon-
strate a critical role for STAT3 and STAT3-dependent tran-
scription factors in the development of central memory in CD8+
T cells and a previously unappreciated role for STAT3 in CD4+
T cell central memory development. Of note, LCMV-infected
GzmbCre/+ Stat3LoxP/LoxP mice or mice with Socs3 silenced in(D) Naive (CD19+CD27lo) and memory (CD19+CD27hi) B cells were sorted from th
allele was measured by real-time PCR.
(E) Naive (CD31+CD27+CD45RO+) STAT3-mosaic CD4+ T cells were stimulated
10 days and mutant-STAT3 transcripts measured.
Data are representative of two independent experiments. All error bars represen
Inaive CD8+ T cells have dramatically reduced frequencies of
LCMV-specific central memory CD8+ T cells memory (Cui
et al., 2011, this issue). This work suggests that STAT3 signaling
and SOCS3 expression within naive T cells are key in steering
CD8+ differentiation away from an effector phenotype and
toward long-term central memory. The proliferation defect ob-
served in AD-HIES naive T cells could reflect a requirement for
STAT3 pathway genes for normal naive T cell division (Durant
et al., 2010) or the failure of STAT3 genes to counter antiprolifer-
ative effects of other STAT pathways such as the IL-27-STAT1
pathway (Liu and Rohowsky-Kochan, 2011). The variability in
the capacity for different patients’ naive cells to proliferate may
stem from the fact that STAT3 mutations in AD-HIES are hypo-
morphic, as opposed to null mutations. This diminished but not
absent function can lead to a wider clinical variability, as well
as unstable cellular phenotypes such as the defects in neutrophil
chemotaxis, which can at times even vary within an individual
patient (Donabedian and Gallin, 1983).
These newly observed clinical findings in AD-HIES may have
other implications as well. Given that atopic dermatitis is a
cardinal feature of AD-HIES, STAT3 pathway defects may also
help explain an observed increased frequency of VZV reactiva-
tion in patients with severe atopic dermatitis (Rystedt et al.,
1986). Additionally, the lower frequency of EBV-specific central
memory T cells in AD-HIES may explain the observed increase
in the number of EBV+ cells in the blood. Although activation of
STAT3 is associated with lymphomagenesis (Bromberg et al.,
1999; Migone et al., 1995; Yu et al., 1995), the paradoxical
increase in risk for B cell lymphomas in these patients with
a loss of STAT3 function now may be understood as resulting
from poor immune control of latently infected cells. This loss of
immune control may explain the EBV+ lymphomas in AD-HIES
and alsomay have effects on the overall control of tumorigenesis,
which has been shown to be partially dependent on central
memory T cells (Klebanoff et al., 2005). Patients with dysfunc-
tional STAT3 signaling may need to be more closely monitored
for control of VZV and EBV, and they may benefit clinically from
early and perhaps frequently boosted VZV vaccination.
The specific defect in T cell central memory formation and
associated loss of control of certain chronic viral infections we
observed in AD-HIES illuminates our understanding of central
memory T cell differentiation and the role of central memory
T cells in immune responses. These insightsmay aid in the devel-
opment of new monitoring and vaccination strategies for long-
term control of chronic viral infections.
EXPERIMENTAL PROCEDURES
Subjects
AD-HIES patients and controls were enrolled under Institutional Review
Board-approved protocol 00-I-0159. The diagnosis of AD-HIES was based
on both phenotypic analysis (a clinical score of > 40) (Grimbacher et al.,
1999) and genetic sequencing of the STAT3 locus. Patients ranged in age
from 2 to 58 years with a mean of 27 years. Males and females were equallye AD-HIES mosaic patient and the frequency of cells with the G1145ASTAT3
with irradiated feeder cells, PHA, with or without anti-IL-2Ra (Daclizumab) for
t standard error of the mean.
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Figure 3. Decrease in Central Memory T Cells in AD-HIES Is Not due to Increased Ex Vivo Apoptosis or Decreased In Vivo Division
(A) PBMCs from five AD-HIES and five healthy controls were thawed and cultured in complete RPMI for 48 hr without stimulation or exogenous cytokine. The
frequency of AnnexinV+7AAD cells was measured by flow cytometry in naive (CD27+CD45RO), central (CD27+CD45RO+), and effector (CD27CD45RO+/)
memory CD4+ and CD8+ subsets.
(B–D) Thawed PBMCs were stained for intracellular Ki67 and gated on CD27+CD45RO+ (central) and CD27CD45RO+/ (effector) T cells.
(B) Representative flow cytometry of Ki67 expression within CD4+CD27+CD45RO+ central memory cells. Graphs depict singlet, aqua viabilityCD3+CD4+
CD27+CD45RO+ cells.
(C) Scatter plots depict Ki67 expression within central and effector T cell subsets of AD-HIES and control PBMCs from two independent experiments *p = 0.0006,
**p = 0.0401, ***p = 0.0093.
(D) Serum levels of IL-2, IL-7, and IL-15 were measured by multiplex cytokine analysis. *p = 0.0014.
All horizontal bars represent median values, and significance was calculated with a two-tailed Mann-Whitney t test with a 95% confidence interval.
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Figure 4. STAT3 Mutant Naive T Cells Have Impaired Proliferation and In Vitro Induction of Central Memory T Cell Phenotypes
(A) Sorted naive (CD27CD45RO) CD4+ T cells were labeled with CFSE and cultured with anti-CD3 and anti-CD28 for 5 days in the presence of IL-2, IL-7, or IL-2
and IL-7. *p = 0.05, **p = 0.05, ***p = 0.05.
(B) Sorted naive (CD27CD45RO) CD8+ T cells were labeled with CFSE and cultured with anti-CD3 and anti-CD28 for 5 days in the presence of IL-2, IL-15, or
IL-2 and IL-15. *p = 0.05, **p = 0.05. All horizontal bars representmedian values, and significancewas calculatedwith a one-tailedMann-Whitney t test with a 95%
confidence interval.
(C and D) After 4 or 5 days, blasting or cells were analyzed for CD62L and CD45RO expression to determine differentiation status. Each bar graph represents an
individual experiment with a unique control and AD-HIES pair. Error bars when present represent standard errors of the mean for cases when sufficient cells
allowed for plating of multiple wells within a single experiment. Different controls and AD-HIES patients were assayed in each experiment.
Immunity
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27 had mutations in the SH2 domain, and 1 had a mutation in the transactiva-
tion domain of STAT3. Peripheral bloodmononuclear cells were prepared from
venous blood by Ficoll-gradient centrifugation and cryopreserved. Most
patients were in a good health and admitted for annual well visits when
samples were drawn.
Flow Cytometry
PBMCs were thawed, washed with PBS, and stained with aqua viability dye
(Invitrogen, Carlsbad, CA) and the following surface and intracellular markers:
CD3-Alexa700, CD8-PacificBlue, CD4-PECy5.5, -APC, CD27-FITC, -PECy5,ICD4RO-TRPE, -PECy7, CD3-Alexa700, CD127-PE, CD62L-FITC, -V450,
AnnexinV-FITC, -APC, 7AAD, Ki67-FITC, IL-2-APC, IFN-g-FITC, TNF-a-PECy7
(all BD Biosciences, San Jose, CA). Events were collected on a LSRFortessa
with Diva 6 software (BD Biosciences) and analyzed with FlowJo 9.1 and 9.3.1
software (Treestar, Ashland, OR). All plots gated on aqua negative (live) singlets
excluding AnnexinV/7AAD staining. The CellTrace CFSE Cell Proliferation Kit
(Invitrogen) was used according to the manufacturer’s protocol. Intracellular
cytokine staining was performed with Cytofix/cytoperm (BD Biosciences). The
FoxP3 staining kit and protocol (eBioscience, San Diego, CA) was used to
stain for Ki67-FITC (BD Biosciences). Populations were sorted with gating
strategies specified in the legends on an Aria II cytometer (BD Biosciences).mmunity 35, 806–818, November 23, 2011 ª2011 Elsevier Inc. 813
Figure 5. STAT3 Mutant Naive T Cells Have Decreased Central Memory-Related Transcription Factor Expression
(A) Naive (CD27+CD45RO) CD4+ and CD8+ T cells were isolated from AD-HIES patients and controls by flow cytometry and transcript levels measured by real-
time PCR. Each point represents the ratio of transcript observed in an AD-HIES patient compared to a corresponding healthy control subject. All data were
collected from separate AD-HIES and control patients.
(B) Naive (CD27+CD45RO), central memory (CD27+CD45RO+), and effector memory (CD27CD45RO+/) CD8+ populations were purified by flow cytometry,
andBCL6 andPRDM1 transcripts weremeasured by real-time PCR. Each set of CD8+ populations was purified from a single individual. Data are representative of
four independent experiments with four AD-HIES patients and four control subjects.
(C) Ratio of BCL6 and PRDM1 transcript levels between AD-HIES and control central and effector memory CD8+ T cell populations. Each point represents the
ratio of transcript observed in an AD-HIES patient compared to their corresponding normal control.
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Expansion of Mosaic T Cells
Naive T cells (aquaCD3+CD4+CD27+CD31+CD45RO and aquaCD3+CD8+
CD27+CD31+CD45RO) were purified by flow cytometry and cultured in RPMI
(GIBCO, Carlsbad, CA) supplemented with 10% fetal calf serum (Gemini
Bio-Products, West Sacramento, CA), 100 U/mL penicillin, 100 mg/mL strepto-
mycin, and 29.2 mg/mL L-glutamine (all GIBCO) (complete RPMI) in the pres-
ence of irradiated PBMCs and purified phytohaemagglutinin (3 mg/mL, Remel
Inc, Lenexa, KS) for 10 days. Anti-IL2Ra (i.e., Daclizumab, 2 or 20 mg/mL,
Roche, Nutley, NJ) was added to cultures as indicated.
Memory T Cell Differentiation and Naive T Cell Stimulation
Naive (aquaCD3+CD4+CD27+CD45RO and aquaCD3+CD8+CD27+
CD45RO) T cells were purified by flow cytometry and cultured in complete
RPMI for 4 to 6 days. Some cells were labeled with CFSE prior to culture. Cells
were stimulated with anti-CD3 (OKT3) (1 mg/mL, eBioscience) and anti-CD28814 Immunity 35, 806–818, November 23, 2011 ª2011 Elsevier Inc.(0.5 mg/mL, BD Biosciences) with the addition of recombinant human IL-2
(20 U/mL, Peprotech, Rocky Hill, NJ), IL-7 (25 ng/mL, a gift from C. Mackall),
and IL-15 (100 ng/mL, Peprotech) as indicated.
Multiplex Cytokine Analysis
Plasma from patients and controls was tested for cytokine expression with the
Meso Scale human assays for the indicated cytokines as per manufacturer’s
instructions (Meso Scale Discovery, Gaithersburg, MD).
PCR Analysis
TCR Rearrangement Excision Circle Analysis
Quantification of TCR rearrangement excision circle (TREC) in sorted CD4+
and CD8+ T cells was done by real-time quantitative PCR with the 50-nuclease
(TaqMan) assay and an ABI7700 system (Perkin-Elmer, Norwalk, CT) as previ-
ously reported (Douek et al., 2000). Cells were lysed in 100 mg/L proteinase K
Figure 6. AD-HIES Patients Have an Increased Risk for VZVReactivation and EBV Viremia alongwith Defects in Virus-Specific T Cell Memory
(A) Kaplan-Meier plot of incidence of herpes zoster (VZV reactivation) in AD-HIES cohort.
(B) Thawed PBMCs were stimulated with inactivated homogenate from VZV-infected cells and the sum of IFN-g, TNF-a, and IL-2 production by total memory
(CD27+CD45RO+ and CD27CD45RO+/) CD4+ T cells was measured relative to unstimulated cells. Data are composite of seven independent experiments.
*p = 0.0127, **p = 0.0089.
(C) The frequency of PBMCs harboring EBV genomes was determined by PCR assay. ***p = 0.0014.
(D) Thawed PBMCs were stimulated with inactivated lysate from EBV-infected cells and IFN-g, TNF-a, and IL-2 levels in total memory (CD27+CD45RO+ and
CD27CD45RO+/) CD4+ and CD8+ T cells were measured by flow cytometry.
(E and F) T cells that produced TNF-a and/or IFN-g in response to EBV were analyzed for their surface expression of CD27 and CD45RO. Data compiled
from seven independent experiments. *p = 0.004, **p = 0.0493. All horizontal bars represent median values, and significance calculated with a two-tailed
Mann-Whitney t test with a 95% confidence interval.
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STAT3 in T Cell Memory(Boehringer, Indianapolis, IN) for 1 hr at 56C, then 10 min at 95C, at
107 cells/mL. Real-time quantitative PCR was done on 5 ml of cell lysate
with the primers CACATCCCTTTCAACCATGCT and GCCAGCTGCAGGGTT
TAGG and probe FAM-50-ACACCTCTGGTTTTTGTAAAGGTGCCCACT-30-
TAMRA (MegaBases, Chicago, IL). PCR reactions contained 0.5 U Platinum
taq polymerase (GIBCO, Grand Island, NY), 3.5 mmol/L MgCl2, 0.2 mmol/L
dNTPs, 500 nmol/L each primer, 150 nmol/L probe, and Blue-636 referenceI(MegaBases). Conditions were 95C for 5 min, then 95C for 30 s, 60C for
1 min, for 40 cycles. A standard curve was plotted, and the numbers of
TREC in samples were calculated by the ABI7700 software.
STAT3 Analysis
Cells sorted from themosaic AD-HIES patient were washed in PBS and lysed in
PureGene DNA Isolation Kit Cell Lysis Solution (Quiagen, Valencia, CA).
Amplification of exons 12–14 of STAT3 was performed with 0.5 mM eachmmunity 35, 806–818, November 23, 2011 ª2011 Elsevier Inc. 815
Table 1. Incidence of Herpes Zoster in AD-HIES
Age
Group Cases
Person
Years
Rate per Year
(95% Cl)
Rate per 1000
Person Years
(95% Cl)
<10 1 608 0.0016 (0.000, 0.0092) 1.6 (0, 9.2)
10–19 8 399 0.0201 (0.0087, 0.0395) 20.1 (8.7, 39.5)
20–29 4 271 0.0111(0.0023, 0.0324) 11.1 (2.3, 32.4)
30–39 3 168 0.0179 (0.0037, 0.0522) 17.9 (3.7, 52.2)
40–49 3 57 0.0702 (0.0191, 0.1797) 70.2 (19.1, 179.7)
>50 0 8 0 0
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STAT3 in T Cell Memoryprimer, 12F amp- 50-TAGTTTAAAGAAATGCCCAGGAGCACAGAGGTTTT-30
and 14R amp- 50-TTTGGCCTGAAGTGACTTTTTGGAATAACTACAGC-30 with
10–100 ng of genomic DNA and Platinum Taq HiFidelity Supermix (Invitrogen).
PCR products were analyzed on an agarose gel and purified with ExoSAP-IT
(USB Corporation, Cleveland, OH). Sequencing was performed with Big Dye
Terminators v3.1 (Applied Biosystems, Foster City, CA) and the following
primers 13-14F 50-CTGGGGACGTTGCAGCTCTCAGAGGGTAAGT-30 and
HpaII R 50-CTCGGCCCCCATTCCCACATCTCT-30. SNP genotyping primer
probe sets for the known SNP in intron 13, rs2293152, and a custom pair
designed to distinguish the 1145A mutation from the 1145G wild-type allele
(Applied Biosystems) were used for quantitative PCR. Reactions were per-
formed in triplicate with 20 ml volume with 10–100 ng DNA per reaction and
23 reaction mix (Applied Biosystems).
Transcript Analysis
RNA was isolated with the RNeasy Mini Kit (Quiagen) as per manufacturer’s
instructions. cDNA was reverse transcribed with the High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). Triplicate real-time PCR
reactions were performed with 20 ml volume with 2 3 reaction mix and the
following primers: 18S Hs99999901_s1, PRDM1 Hs00153357_m1, BCL6
Hs00277037_m1, and SOCS3 Hs01000485_g1 (Applied Biosystems). Tran-
scripts were measured relative to 18S levels to normalize for cDNA input.
STAT3 and transcript PCR reactions underwent 40 cycles and were
analyzed on an ABI 7500 Real Time Thermal Cycler (Applied Biosystems).
Viral Memory Response
PBMCs were thawed and rested in complete RPMI for 2 hr. 1–2 3 106 cells
were stimulated with Staphylococcus enterotoxin B as a positive control
(Sigma, St. Louis, MO), EBV-infected cell extract (Virusys Corporation, Taney-
town, MD), or varicella zoster grade 2 antigen (Microbix Biosystems Inc.,
Ontario, CA) for 2 hr before the addition of Brefeldin A (10 mg/mL, Sigma). After
16 hr of stimulation, cells were washed twice with PBS and stained for flow
cytometric analysis.
EBV Viral Titers
Cells were diluted in 1 3 RPMI Medium 1640 (Invitrogen) to obtain a final
concentration of 13 106 cells/ml. DNAwas extractedwith the NucliSens easy-
MAG system (bioMerieux, Marcy I’Etoile, France) according to the manufac-
turer’s recommendations and eluted with 50 ml elution buffer. EBV quantitative
real-time PCR (qPCR) was performed with the Rotor-Gene 3000 instrument
(QIAGEN) with amplification and detection of a 192 bp segment from the
BamHI-W gene with primers and dual hybridization probes described previ-
ously (Feng et al., 2004). The 20 ml reactions consisted of 13QuantiTect Probe
PCR master mix (QIAGEN) containing HotStarTaq DNA polymerase, reaction
buffer, 4.0 mM MgCl2, dNTP mix (containing a dTTP/dUTP mixture), and
ROX passive reference dye, and 0.5 mM of each primer, 0.2 mM of each probe,
0.5 U UNG, and 5 ml of extracted DNA. The reaction mixture was preincubated
for 10 min at 30C to activate UNG and then DNA was denatured and UNG
inactivated at 95C for 10 min. The EBV template was first amplified by five
cycles of 15 s at 95C and 40 s at 72C followed by a touch-down procedure
consisting of six cycles of 15 s at 95C, 30 s at 72C to 55C with a 3C
decrease in annealing temperature at each cycle, and 30 s at 72C. This
was then followed by an additional 40 cycles of 15 s at 95C, 30 s at 55C,
and 30 s at 72C. Prior to extraction, each sample was spiked with an internal816 Immunity 35, 806–818, November 23, 2011 ª2011 Elsevier Inc.control (pBR322 plasmid DNA) to verify successful recovery of DNA and
removal of PCR inhibitors. The internal control in extracted samples was de-
tected by amplification in a separate qualitative real-time PCR as described
previously (Cohen et al., 2010). A plasmid containing the EBV amplification
sites in pCR2.1 vector (Invitrogen) were linearized and then diluted in TRIS-
EDTA buffer (pH 8.0) with glycogen (33.3 mg/ml) to obtain a dilution series for
the generation of a standard curve of 5–1 3 106 genome copies per reaction
volume. For each positive sample, the Rotor-Gene 3000 software plotted
the crossing threshold value on this curve to determine the number of target
copies present in the amplification reaction.Statistics
All error bars depict median values. Statistical significance was calculated
from the median value with a one- or two-tailed Mann-Whitney test with
GraphPad Prism 5.0 software (GraphPad Software Inc., La Jolla, CA).
Incidence rates for first occurrence of herpes zoster were determined by
dividing the number of cases that occurred during the indicated decade of
life by the number of person-years at risk lived during this decade. Exact confi-
dence intervals for these rates were computed based on the assumption that
the cases followed a Poisson distribution. Incidence rates for recurrence were
calculated by dividing the number of cases of recurrence by the total person
years after the first case of herpes zoster among thosewho already had herpes
zoster until the current age or age at recurrence when present. The Kaplan-
Meier plot of herpes zoster incidence and statistical significance was calcu-
lated with GraphPad Prism 5.0 software.SUPPLEMENTAL INFORMATION
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